370 related articles for article (PubMed ID: 32710500)
41. SARS-CoV-2 Infection and Severity in Patients with Hematologic Malignancies: A Systematic Review.
SeyedAlinaghi S; Karimi A; Mirzapour P; Salmani R; Razi A; Mojdeganlou H; Mojdeganlou P; Qodrati M; Jashaninejad R; Paranjkhoo P; Dadras O; Zarezadeh B; Afsahi AM; Afzalian A; Varshochi S; Mehraeen E; Afsahi G
Infect Disord Drug Targets; 2023; 23(7):29-38. PubMed ID: 37138433
[TBL] [Abstract][Full Text] [Related]
42. Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2.
Shaw B; Shortt J; Low M; Rogers B; Kaplan Z; Fedele P; Gregory G; Vilcassim S; Gilbertson M; Grigoriadis G; Opat S
Intern Med J; 2022 Dec; 52(12):2172-2175. PubMed ID: 36436197
[TBL] [Abstract][Full Text] [Related]
43. Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: A multicentre prospective cohort.
Minoia C; Diella L; Perrone T; Loseto G; Pelligrino C; Attolico I; Pasciolla C; Totaro V; De Candia MS; Spada V; Clemente F; Camporeale M; Di Gennaro F; Guarini A; Musto P; Saracino A; Bavaro DF
Br J Haematol; 2023 Sep; 202(5):928-936. PubMed ID: 37259629
[TBL] [Abstract][Full Text] [Related]
44. The management of hematologic malignancies during the COVID-19 pandemic.
Hus I; Salomon-Perzyński A; Tomasiewicz K; Robak T
Expert Opin Pharmacother; 2021 Apr; 22(5):565-582. PubMed ID: 33342308
[No Abstract] [Full Text] [Related]
45. Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis.
Naimi A; Yashmi I; Jebeleh R; Imani Mofrad M; Azimian Abhar S; Jannesar Y; Heidary M; Pakzad R
J Clin Lab Anal; 2022 May; 36(5):e24387. PubMed ID: 35385130
[TBL] [Abstract][Full Text] [Related]
46. In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain.
Suárez-García I; Perales-Fraile I; González-García A; Muñoz-Blanco A; Manzano L; Fabregate M; Díez-Manglano J; Aizpuru EF; Fernández FA; García AG; Gómez-Huelgas R; Ramos-Rincón JM;
PLoS One; 2021; 16(8):e0255524. PubMed ID: 34343222
[TBL] [Abstract][Full Text] [Related]
47. Hematopoietic cell transplantation during COVID-19 pandemic: experience from a tertiary hospital in Madrid.
Lázaro Del Campo P; Ramírez López A; de la Cruz Benito B; de Paz Arias R; de Soto Álvarez T; Sánchez Vadillo I; Humala Barbier K; García Pérez E; Dos Santos Ortas A; López de la Guía A; Gasior Kabat M; Baltasar Tello P; Jiménez Yuste V; Canales Albendea M
Expert Rev Hematol; 2021 Jan; 14(1):1-5. PubMed ID: 33280467
[No Abstract] [Full Text] [Related]
48. Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2.
Schwartz DA; Morotti D
Viruses; 2020 Nov; 12(11):. PubMed ID: 33203131
[TBL] [Abstract][Full Text] [Related]
49. A new COVID-19 prediction scoring model for in-hospital mortality: experiences from Turkey, single center retrospective cohort analysis.
Doganci S; Ince ME; Ors N; Yildirim AK; Sir E; Karabacak K; Eksert S; Ozgurtas T; Tasci C; Dogan D; Ozkan G; Cosar A; Gulcelik MA; Aydin K; Yildirim V; Erdol C
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10247-10257. PubMed ID: 33090436
[TBL] [Abstract][Full Text] [Related]
50. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.
Chatzikonstantinou T; Kapetanakis A; Scarfò L; Karakatsoulis G; Allsup D; Cabrero AA; Andres M; Antic D; Baile M; Baliakas P; Bron D; Capasso A; Chatzileontiadou S; Cordoba R; Correa JG; Cuéllar-García C; De Paoli L; De Paolis MR; Del Poeta G; Demosthenous C; Dimou M; Donaldson D; Doubek M; Efstathopoulou M; Eichhorst B; El-Ashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Foglietta M; Frederiksen H; Fürstenau M; García-Marco JA; García-Serra R; Gentile M; Gimeno E; Glenthøj A; Gomes da Silva M; Gutwein O; Hakobyan YK; Herishanu Y; Hernández-Rivas JÁ; Herold T; Innocenti I; Itchaki G; Jaksic O; Janssens A; Kalashnikova ОB; Kalicińska E; Karlsson LK; Kater AP; Kersting S; Labrador J; Lad D; Laurenti L; Levin MD; Lista E; Lopez-Garcia A; Malerba L; Marasca R; Marchetti M; Marquet J; Mattsson M; Mauro FR; Milosevic I; Mirás F; Morawska M; Motta M; Munir T; Murru R; Niemann CU; Rodrigues RN; Olivieri J; Orsucci L; Papaioannou M; Pavlovsky MA; Piskunova I; Popov VM; Quaglia FM; Quaresmini G; Qvist K; Reda G; Rigolin GM; Ruchlemer R; Saghumyan G; Shrestha A; Šimkovič M; Špaček M; Sportoletti P; Stanca O; Stavroyianni N; Tadmor T; Te Raa D; Tonino SH; Trentin L; Van Der Spek E; van Gelder M; van Kampen R; Varettoni M; Visentin A; Vitale C; Wasik-Szczepanek E; Wróbel T; San Segundo LY; Yassin M; Coscia M; Rambaldi A; Montserrat E; Foà R; Cuneo A; Stamatopoulos K; Ghia P
Leukemia; 2021 Dec; 35(12):3444-3454. PubMed ID: 34725454
[TBL] [Abstract][Full Text] [Related]
51. The role of haematological parameters in patients with COVID-19 and influenza virus infection.
Kazancioglu S; Bastug A; Ozbay BO; Kemirtlek N; Bodur H
Epidemiol Infect; 2020 Nov; 148():e272. PubMed ID: 33148349
[TBL] [Abstract][Full Text] [Related]
52. Changes in mortality associated with different hematologic malignancies during the pandemic in the United States.
Fedeli U; Barbiellini Amidei C; Han X; Jemal A
Int J Cancer; 2024 May; 154(10):1703-1708. PubMed ID: 38335457
[TBL] [Abstract][Full Text] [Related]
53. A comprehensive approach to therapy of haematological malignancies in older patients.
Cordoba R; Eyre TA; Klepin HD; Wildes TM; Goede V
Lancet Haematol; 2021 Nov; 8(11):e840-e852. PubMed ID: 34624238
[TBL] [Abstract][Full Text] [Related]
54. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
55. COVID-19 infection in patients with haematological disease - A tertiary centre experience from north India.
Aggarwal M; Amjad MS; Khandelwal A; Kumar P; Dhawan R; Dass J; Ganesh KV; Khanna P; Singh AK; Soni KD; Agarwal R; Bairwa M; Selvi A; Tyagi S; Seth T; Mahapatra M; Wig N; Trikha A
Indian J Med Res; 2022; 155(5&6):570-574. PubMed ID: 35975348
[TBL] [Abstract][Full Text] [Related]
56. Early Risk Factors for the Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Positivity in Patients With Coronavirus Disease 2019.
Lin A; He ZB; Zhang S; Zhang JG; Zhang X; Yan WH
Clin Infect Dis; 2020 Nov; 71(16):2061-2065. PubMed ID: 32337591
[TBL] [Abstract][Full Text] [Related]
57. Impact of COVID 19 on red flag discussions for haematological malignancies within the Belfast trust.
Waddell D; Benson G
Ulster Med J; 2021 May; 90(2):77-80. PubMed ID: 34276084
[TBL] [Abstract][Full Text] [Related]
58. Clinical Course of COVID-19 and Cycle Threshold in Patients with Haematological Neoplasms.
Santarelli IM; Sierra M; Vaulet MLG; Fermepin MR; Fernández SI
Prague Med Rep; 2022; 123(4):250-257. PubMed ID: 36416463
[TBL] [Abstract][Full Text] [Related]
59. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches.
Kakavandi S; Hajikhani B; Azizi P; Aziziyan F; Nabi-Afjadi M; Farani MR; Zalpoor H; Azarian M; Saadi MI; Gharesi-Fard B; Terpos E; Zare I; Motamedifar M
Cell Commun Signal; 2024 Feb; 22(1):126. PubMed ID: 38360719
[TBL] [Abstract][Full Text] [Related]
60. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
